Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
8,861,488
-
Share change
-
+5,057,713
-
Total reported value
-
$171,025,000
-
Price per share
-
$19.30
-
Number of holders
-
36
-
Value change
-
+$96,062,128
-
Number of buys
-
29
-
Number of sells
-
9
Institutional Holders of Vincerx Pharma, Inc. - Common Stock (VINC) as of Q1 2021
As of 31 Mar 2021,
Vincerx Pharma, Inc. - Common Stock (VINC) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,861,488 shares.
The largest 10 holders included
SAGE RHINO CAPITAL LLC, WELLINGTON MANAGEMENT GROUP LLP, Holocene Advisors, LP, Affinity Asset Advisors, LLC, RTW INVESTMENTS, LP, PUTNAM INVESTMENTS LLC, TANG CAPITAL MANAGEMENT LLC, Logos Global Management LP, Ikarian Capital, LLC, and CITADEL ADVISORS LLC.
This page lists
36
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.